首页> 外文学位 >Evaluation of hot-melt extrusion technology to improve dissolution rates of poorly water soluble drugs.
【24h】

Evaluation of hot-melt extrusion technology to improve dissolution rates of poorly water soluble drugs.

机译:评估热熔挤出技术以改善水溶性差的药物的溶出度。

获取原文
获取原文并翻译 | 示例

摘要

The bioavailability of orally administered drugs mainly depends on solubility and permeability. Since the advent of high throughput screening (HTS) in drug discovery process the resultant compounds are often high molecular weight and highly lipophilic, that show poor solubility. Scientists have tried to address solubility issues by various pharmaceutical interventions. Today amongst many methods available to improve solubility and dissolution rate, preparation of solid dispersions and solid solutions has gained enormous attention.; Hot-melt extrusion is one of the most widely applied processing technologies in the plastic, rubber and food industry. Today this technology has found its place in the array of pharmaceutical manufacturing operations. Melt extrusion processes are currently applied in the pharmaceutical field for the manufacture of a verity of dosage forms and formulations such as granules, pellets, tablets, implants, transdermal systems and ophthalmic inserts. In this study the melt extrusion process is evaluated to formulate solid dispersion and solid solution of poorly water soluble model drug.; The primary objective of this study is to evaluate the utility of hot-melt extrusion (HME) in improving the dissolution rate of a poorly water-soluble model drug (Indomethacin) using suitable hydrophilic polymers such as Eudragit EPO (EPO), Polyvinyl pyrrolidone-vinyl acetate copolymer (PVP-VA), Polyvinylpyrrolidone K30 (PVPK30), Poloxamer 188 (P188). The secondary objective is to characterize physical and viscoelastic properties of materials prior to the actual melt extrusion process to assess their suitability for HME process and to establish correlation between these assessments with HME process parameters. To achieve these objectives, the research plan is mainly divided in to three broad sections: (1) Physico-mechanical evaluation of drug and polymer binary mixtures prior to hot-melt extrusion (thermal analysis, viscoelastic evaluation and solubility parameters). (2) Evaluation of hot-melt extrusion process parameters (such as barrel temperatures, motor load, screw speed, feed rate, melt pressure etc.) for the various formulations. (3) The performance attributes of hot-melt extrudate such as solid state characterization (differential scanning calorimetry, powder x-ray diffraction, FTIR spectroscopy), intrinsic dissolution rate studies and stability studies.
机译:口服药物的生物利用度主要取决于溶解度和渗透性。由于在药物发现过程中出现了高通量筛选(HTS),因此所得化合物通常具有高分子量和高亲脂性,显示出较差的溶解性。科学家试图通过各种药物干预来解决溶解度问题。如今,在许多可用于提高溶解度和溶解速率的方法中,固体分散体和固体溶液的制备已引起了极大的关注。热熔挤出是塑料,橡胶和食品工业中应用最广泛的加工技术之一。如今,这项技术已在制药生产操作中找到了自己的位置。熔体挤出法目前在制药领域中用于制造各种剂型和制剂,例如颗粒剂,丸剂,片剂,植入物,透皮系统和眼科插件。在这项研究中,对熔融挤出过程进行了评估,以配制水溶性差的模型药物的固体分散体和固溶体。这项研究的主要目的是评估热熔挤出(HME)在使用适当的亲水性聚合物(例如Eudragit EPO(EPO),聚乙烯吡咯烷酮-)改善水溶性差的模型药物(吲哚美辛)的溶出度中的效用。乙酸乙烯酯共聚物(PVP-VA),聚乙烯吡咯烷酮K30(PVPK30),泊洛沙姆188(P188)。第二个目的是在实际的熔体挤出工艺之前表征材料的物理和粘弹性,以评估其对HME工艺的适用性,并在这些评估与HME工艺参数之间建立关联。为了实现这些目标,研究计划主要分为三个主要部分:(1)在热熔挤出之前对药物和聚合物二元混合物进行物理力学评估(热分析,粘弹性评估和溶解度参数)。 (2)评估各种配方的热熔挤出工艺参数(例如机筒温度,电机负载,螺杆速度,进料速率,熔体压力等)。 (3)热熔挤出物的性能属性,例如固态表征(差示扫描量热法,粉末X射线衍射,FTIR光谱),固有溶解速率研究和稳定性研究。

著录项

  • 作者

    Chokshi, Rina.;

  • 作者单位

    University of Rhode Island.;

  • 授予单位 University of Rhode Island.;
  • 学科 Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 188 p.
  • 总页数 188
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号